43% Jumps in Net Profit: Small-Cap Stock from Hospital Sector Hit 52-Week High Today
Kiran DSIJCategories: Mindshare, Trending
The company has a market cap of Rs 7,600 crore with a PE of 36x, an ROE of 21 per cent and an ROCE of 20 per cent.
On Thursday, shares of Park Medi World Ltd jumped 5.5 per cent and hit a fresh 52-week high of Rs 179.55 per share from its previous closing of Rs 170.25 per share. The shares of the company saw a Spurt in Volume by more than 1.06 times on the BSE.
Park Medi World Ltd has significantly expanded its regional footprint through the 100 per cent acquisition of KP Institute of Medical Sciences (KPIMS) in Agra for approximately Rs 245 crore. This all-cash transaction, executed via its subsidiary Blue Heavens Health Care Pvt Ltd, adds a 360-bed, NABH-accredited facility to the portfolio, strengthening the group's presence in Uttar Pradesh under a strategic cluster-based expansion model. Alongside the integration of Krishna Super Speciality Hospital in Bhatinda and Febris Multi-Speciality Hospital in Narela, these acquisitions bolster the group's capacity in high-potential urban catchments. By focusing on operational efficiencies and clinical strengthening, the company remains on track to reach its target of 5,260 beds by March 2028 while maintaining its mission of providing affordable healthcare to underserved populations.
According to its Quarterly Results, the net sales increased by 18 per cent to Rs 410 crore and net profit increased by 16 per cent to Rs 52.80 crore in Q3FY26 compared to Q3FY25. In 9MFY26, the net sales increased by 17 per cent to Rs 1,218.90 crore and net profit increased by 43 per cent to Rs 196.80 crore compared to 9MFY25.
About the Company
Park Medi World Ltd is a prominent healthcare provider and the second-largest private hospital chain in North India, holding a leading position in Haryana. The company operates 14 NABH-accredited multi-super-specialty hospitals under the "Park" brand, dedicated to providing accessible medical services to middle-income patients. Its comprehensive clinical infrastructure supports over 30 specialties—including cardiology, oncology, neurology and orthopaedics—encompassing a full spectrum of care from maternity and child welfare to advanced surgical interventions.
The company has a market cap of Rs 7,600 crore with a PE of 36x, an ROE of 21 per cent and an ROCE of 20 per cent. The stock is up by 30 per cent from its 52-week low of Rs 138.15 per share.
Disclaimer: The article is for informational purposes only and not investment advice.